Nyxoah (NYXH) EBITDA Margin Growth (1y) (2022 - 2026)
Nyxoah (NYXH) EBITDA Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 314.00 |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -658.00 |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -285.00 |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 192.00 |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 48.00 |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -2,130.00 |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -331.00 |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 26.00 |
| 10 | Nyxoah | 56.02 Mn | 103.00 Mn | 4.26 Mn | -638.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -638.00 |
| Dec 31, 2025 | -204.58 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | -25,005.00 |
| Mar 31, 2025 | -107.87 Mn |
| Dec 31, 2024 | -66.80 Bn |
| Sep 30, 2024 | -1.34 Mn |
| Jun 30, 2024 | 64,305.00 |
| Mar 31, 2024 | -265.38 Bn |
| Dec 31, 2023 | 66.96 Bn |
| Sep 30, 2023 | -374,489.00 |
| Jun 30, 2023 | 29,787.00 |
| Mar 31, 2023 | 265.49 Bn |
| Dec 31, 2022 | -246.51 Bn |
| Sep 30, 2022 | 99,475.00 |
| Jun 30, 2022 | 463,533.00 |